FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds with common formulae I, II, IV and V: (I), (III), (IV), (V), values of radicals, such as provided in invention formula. Besides, proposed invention relates to pharmaceutical composition on the basis of above-described compounds, to their application, and also to method for treatment of repeated urination, incontinence and higher activity of urinary bladder, besides, to method to treat pain.
EFFECT: new compounds have been produced and described, which may be useful for treatment of diseases related to fatty-acid amide-hydrolase (FAAH), in particular to treat repeated urination and incontinence, higher activity of bladder and/or pain.
16 cl, 442 ex, 73 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDYL NONAROMATIC NITROGEN-CONTAINING HETEROCYCLO-1-CARBOXYLATE DERIVATIVE | 2006 |
|
RU2408580C2 |
CONDENSING DICYCLIC NITROGEN CONTAINING HETEROCYCLES, WHICH HAVE DGAT INHIBITING ACTION | 2003 |
|
RU2342388C2 |
AZOLE COMPOUNDS | 2009 |
|
RU2493154C2 |
C-FMC KINASE INHIBITORS | 2007 |
|
RU2475483C2 |
DIAMINE DERIVATIVES | 2003 |
|
RU2333203C2 |
BENZOTHIOPHENE COMPOUND | 2014 |
|
RU2667507C2 |
PYRAZOLE DERIVATIVES | 2004 |
|
RU2332412C2 |
PYRIMIDYL INDOLINE COMPOUND | 2008 |
|
RU2464269C2 |
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
BENZIMIDAZOLE DERIVATIVES, BASED PHARMACEUTICAL COMPOSITION AND METHODS OF USING THEM | 2008 |
|
RU2456276C2 |
Authors
Dates
2011-01-10—Published
2006-02-16—Filed